Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morris Karmazyn

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Journal of Molecular and Cellular Cardiology|February 23, 2013
NHE-1: still a viable therapeutic targetMorris Karmazyn
International Journal of Molecular Sciences|July 29, 2025
Special Issue "Cellular and Molecular Biology of Cardiac Hypertrophy and Heart Failure: Pathogenesis, Diagnostics and Treatment"Morris Karmazyn
Current Vascular Pharmacology|November 1, 2006
Leptin and vascular smooth muscleAsad Zeidan, Morris Karmazyn
The Journal of Pharmacology and Experimental Therapeutics|March 10, 2004
Obligatory role for endogenous endothelin in mediating the hypertrophic effects of phenylephrine and angiotensin II in neonatal rat ventricular myocytes: evidence for two distinct mechanisms for endothelin regulationYing Xia, Morris Karmazyn
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|January 28, 2005
The cardiac Na-H exchanger: a key downstream mediator for the cellular hypertrophic effects of paracrine, autocrine and hormonal factorsLarry Fliegel, Morris Karmazyn
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|June 28, 2007
Mitochondrial permeability transition pore opening as an endpoint to initiate cell death and as a putative target for cardioprotectionSabzali Javadov, Morris Karmazyn
Current Pharmaceutical Design|May 22, 2013
Leptin as a cardiac pro-hypertrophic factor and its potential role in the development of heart failureMorris Karmazyn, Venkatesh Rajapurohitam
Canadian Journal of Physiology and Pharmacology|June 26, 2018
Cardioprotection by ginseng: experimental and clinical evidence and underlying mechanismsXiaohong Tracey Gan, Morris Karmazyn
Molecular and Cellular Biochemistry|March 9, 2023
Probiotics as potential treatments to reduce myocardial remodelling and heart failure via the gut-heart axis: State-of-the-art reviewMorris Karmazyn, Xiaohong Tracey Gan
International Journal of Molecular Sciences|January 23, 2024
Molecular and Cellular Mechanisms Underlying the Cardiac Hypertrophic and Pro-Remodelling Effects of LeptinMorris Karmazyn, Xiaohong Tracey Gan
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Journal of Molecular and Cellular Cardiology|February 23, 2013
NHE-1: still a viable therapeutic targetMorris Karmazyn
International Journal of Molecular Sciences|July 29, 2025
Special Issue "Cellular and Molecular Biology of Cardiac Hypertrophy and Heart Failure: Pathogenesis, Diagnostics and Treatment"Morris Karmazyn
Current Vascular Pharmacology|November 1, 2006
Leptin and vascular smooth muscleAsad Zeidan, Morris Karmazyn
The Journal of Pharmacology and Experimental Therapeutics|March 10, 2004
Obligatory role for endogenous endothelin in mediating the hypertrophic effects of phenylephrine and angiotensin II in neonatal rat ventricular myocytes: evidence for two distinct mechanisms for endothelin regulationYing Xia, Morris Karmazyn
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|January 28, 2005
The cardiac Na-H exchanger: a key downstream mediator for the cellular hypertrophic effects of paracrine, autocrine and hormonal factorsLarry Fliegel, Morris Karmazyn
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|June 28, 2007
Mitochondrial permeability transition pore opening as an endpoint to initiate cell death and as a putative target for cardioprotectionSabzali Javadov, Morris Karmazyn
Current Pharmaceutical Design|May 22, 2013
Leptin as a cardiac pro-hypertrophic factor and its potential role in the development of heart failureMorris Karmazyn, Venkatesh Rajapurohitam
Canadian Journal of Physiology and Pharmacology|June 26, 2018
Cardioprotection by ginseng: experimental and clinical evidence and underlying mechanismsXiaohong Tracey Gan, Morris Karmazyn
Molecular and Cellular Biochemistry|March 9, 2023
Probiotics as potential treatments to reduce myocardial remodelling and heart failure via the gut-heart axis: State-of-the-art reviewMorris Karmazyn, Xiaohong Tracey Gan
International Journal of Molecular Sciences|January 23, 2024
Molecular and Cellular Mechanisms Underlying the Cardiac Hypertrophic and Pro-Remodelling Effects of LeptinMorris Karmazyn, Xiaohong Tracey Gan
Pageof 9